FDA official logo
GSRS logo
PFDA official logo

DAUNORUBICIN

  • UNII: ZS7284E0ZP
  • Formula: C27H29NO10
  • Preferred Substance Name: DAUNORUBICIN
  • InChIKey: STQGQHZAVUOBTE-VGBVRHCVSA-N

  • 20830-81-3
  • 244-069-7
  • (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
  • (8S,10S)-8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-6,8,11-TRIHYDROXY-1-METHOXY-7,8,9,10-TETRAHYDROTETRACENE-5,12-DIONE
  • 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)-
  • DAUNOMYCIN
  • DAUNOMYCIN [IARC]
  • DAUNORUBICIN [HSDB]
  • DAUNORUBICIN [INN]
  • DAUNORUBICIN [MART.]
  • DAUNORUBICIN [MI]
  • DAUNORUBICIN [ORANGE BOOK]
  • DAUNORUBICIN [VANDF]
  • DAUNORUBICIN [WHO-DD]
  • DOXORUBICIN HYDROCHLORIDE IMPURITY A [EP IMPURITY]
  • EPIRUBICIN HYDROCHLORIDE IMPURITY D [EP IMPURITY]
  • EPIRUBICIN HYDROCHLORIDE IMPURITY, DAUNORUBICIN- [USP IMPURITY]
  • EPIRUBICIN IMPURITY D
  • FI 6339
  • FI-6339
  • NSC-83142
  • RP 13057
  • RP-13057
  • VALRUBICIN IMPURITY, DAUNORUBICIN [USP IMPURITY]
  • VYXEOS COMPONENT DAUNORUBICIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.